Tag:
Everolimus
Latest Headlines
Latest Headlines
Novartis' Afinitor shrinks tumors in 33% of patients
Shares of Novartis were buoyed by the news that its experimental cancer drug Afinitor cut the size of tumors by half or more in a third of patients recruited for a mid-stage study. And Novartis said
Novartis wins FDA approval for cancer blockbuster
The FDA has approved Novartis' Afinitor (everolimus) to treat the most common kind of kidney cancer. And analysts predict that the drug is on track to become a blockbuster, with new approvals for
Data drives Novartis' cancer drug to late-stage trial
Novartis says that its experimental cancer therapy Afinitor produced positive data in a mid-stage trial, setting the stage for a late-stage study. The research team now plans to begin enrolling
